Literature DB >> 1702722

CD27 expression by a distinct subpopulation of human B lymphocytes.

D Maurer1, W Holter, O Majdic, G F Fischer, W Knapp.   

Abstract

CD27 is present on the surface of a major subset of peripheral blood T lymphocytes. In this report we show that CD27 is also expressed on a subpopulation of the normal human B cell lineage which is absent from cord blood but present in tonsils and in the peripheral blood of adult individuals. CD27+ B lymphocytes are characterized by the following criteria: (a) in terms of physical properties, the CD27+ B cells form a population with an increased cell size combined with a decreased cell density; (b) the CD27 expression of tonsillar B lymphocytes is postively correlated with mIgA but negatively correlated with membrane IgM/membrane IgD positivity; (c) CD27 on B cells can be induced selectively by the combination of Staphylococcus aureus plus interleukin 2, but not by either treatment alone, and (d) CD27+ B lymphocytes express high levels of the adhesion structures LFA-1 (CD11a), ICAM-1 (CD54), LFA-3 (CD58) and of the lymphocyte homing receptor CD44. These latter findings suggest that CD27+ B cells are predispose to form cell-cell interactions. Accordingly, within 3 h of cell culture CD27+, but not CD27-, B lymphocytes were found to form LFA-1-mediated homotypic B cell clusters.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1702722     DOI: 10.1002/eji.1830201223

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  34 in total

1.  CD27/CD70 interaction directly induces natural killer cell killing activity.

Authors:  F C Yang; K Agematsu; T Nakazawa; T Mori; S Ito; T Kobata; C Morimoto; A Komiyama
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

2.  Late signals from CD27 prevent Fas-dependent apoptosis of primary CD8+ T cells.

Authors:  Douglas V Dolfi; Alina C Boesteanu; Constantinos Petrovas; Dong Xia; Eric A Butz; Peter D Katsikis
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

Review 3.  Surface molecules involved in B lymphocyte function.

Authors:  P Möller; A Eichelmann; G Moldenhauer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

4.  Key developmental transitions in human germinal center B cells are revealed by differential CD45RB expression.

Authors:  Stephen M Jackson; Natessa Harp; Darshna Patel; Jordan Wulf; Erich D Spaeth; Uzoamaka K Dike; Judith A James; J Donald Capra
Journal:  Blood       Date:  2008-12-04       Impact factor: 22.113

Review 5.  Roles of TRAF molecules in B lymphocyte function.

Authors:  Ping Xie; Zachary J Kraus; Laura L Stunz; Gail A Bishop
Journal:  Cytokine Growth Factor Rev       Date:  2008-05-21       Impact factor: 7.638

6.  Antigen-presenting cell-derived signals determine expression levels of CD70 on primed T cells.

Authors:  S M Lens; P A Baars; B Hooibrink; M H van Oers; R A van Lier
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

7.  Effects of CD70 and CD11a in immune thrombocytopenia patients.

Authors:  Li Ma; Zeping Zhou; Hairong Jia; Hu Zhou; Aiping Qi; Huiyuan Li; Hongmei Wang; Lei Zhang; Renchi Yang
Journal:  J Clin Immunol       Date:  2011-05-04       Impact factor: 8.317

8.  N-acetylcysteine inhibits the induction of an antigen-specific antibody response down-regulating CD40 and CD27 co-stimulatory molecules.

Authors:  L Giordani; M G Quaranta; W Malorni; M Boccanera; E Giacomini; M Viora
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

9.  Systematic comparison of gene expression between murine memory and naive B cells demonstrates that memory B cells have unique signaling capabilities.

Authors:  Mary M Tomayko; Shannon M Anderson; Catherine E Brayton; Saheli Sadanand; Natalie C Steinel; Timothy W Behrens; Mark J Shlomchik
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

10.  Children with chronic renal failure have reduced numbers of memory B cells.

Authors:  A H M Bouts; J C Davin; R T Krediet; L A H Monnens; J Nauta; C H Schröder; R A W van Lier; T A Out
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.